BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Malouli D, Hansen SG, Hancock MH, Hughes CM, Ford JC, Gilbride RM, Ventura AB, Morrow D, Randall KT, Taher H, Uebelhoer LS, McArdle MR, Papen CR, Espinosa Trethewy R, Oswald K, Shoemaker R, Berkemeier B, Bosche WJ, Hull M, Greene JM, Axthelm MK, Shao J, Edlefsen PT, Grey F, Nelson JA, Lifson JD, Streblow D, Sacha JB, Früh K, Picker LJ. Cytomegaloviral determinants of CD8+ T cell programming and RhCMV/SIV vaccine efficacy. Sci Immunol 2021;6:eabg5413. [PMID: 33766849 DOI: 10.1126/sciimmunol.abg5413] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Brochu H, Wang R, Tollison T, Pyo CW, Thomas A, Tseng E, Law L, Picker LJ, Gale M Jr, Geraghty DE, Peng X. Alternative splicing and genetic variation of mhc-e: implications for rhesus cytomegalovirus-based vaccines. Commun Biol 2022;5:1387. [PMID: 36536032 DOI: 10.1038/s42003-022-04344-2] [Reference Citation Analysis]
2 Malouli D, Gilbride RM, Wu HL, Hwang JM, Maier N, Hughes CM, Newhouse D, Morrow D, Ventura AB, Law L, Tisoncik-Go J, Whitmore L, Smith E, Golez I, Chang J, Reed JS, Waytashek C, Weber W, Taher H, Uebelhoer LS, Womack JL, McArdle MR, Gao J, Papen CR, Lifson JD, Burwitz BJ, Axthelm MK, Smedley J, Früh K, Gale M Jr, Picker LJ, Hansen SG, Sacha JB. Cytomegalovirus-vaccine-induced unconventional T cell priming and control of SIV replication is conserved between primate species. Cell Host Microbe 2022;30:1207-1218.e7. [PMID: 35981532 DOI: 10.1016/j.chom.2022.07.013] [Reference Citation Analysis]
3 Wallace Z, Singh PK, Dorrell L. Combination strategies to durably suppress HIV-1: Soluble T cell receptors. Journal of Virus Eradication 2022;8:100082. [DOI: 10.1016/j.jve.2022.100082] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Haynes BF, Wiehe K, Borrrow P, Saunders KO, Korber B, Wagh K, McMichael AJ, Kelsoe G, Hahn BH, Alt F, Shaw GM. Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies. Nat Rev Immunol 2022;:1-17. [PMID: 35962033 DOI: 10.1038/s41577-022-00753-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
5 Medetgul-Ernar K, Davis MM. Standing on the shoulders of mice. Immunity 2022;55:1343-53. [PMID: 35947979 DOI: 10.1016/j.immuni.2022.07.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
6 Brackenridge S, Borrow P, Mcmichael A. Regulation of the cell surface expression of classical and non-classical MHC proteins by the human cytomegalovirus UL40 and rhesus cytomegalovirus rh67 proteins.. [DOI: 10.1101/2022.07.22.501209] [Reference Citation Analysis]
7 Hansen SG, Hancock MH, Malouli D, Marshall EE, Hughes CM, Randall KT, Morrow D, Ford JC, Gilbride RM, Selseth AN, Trethewy RE, Bishop LM, Oswald K, Shoemaker R, Berkemeier B, Bosche WJ, Hull M, Silipino L, Nekorchuk M, Busman-Sahay K, Estes JD, Axthelm MK, Smedley J, Shao D, Edlefsen PT, Lifson JD, Früh K, Nelson JA, Picker LJ. Myeloid cell tropism enables MHC-E-restricted CD8(+) T cell priming and vaccine efficacy by the RhCMV/SIV vaccine. Sci Immunol 2022;7:eabn9301. [PMID: 35714200 DOI: 10.1126/sciimmunol.abn9301] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
8 Brackenridge S, Borrow P, Mcmichael AJ. Mapping the epitopes of the Human Leukocyte Antigen E antibodies 3D12 and 4D12.. [DOI: 10.1101/2022.05.27.493692] [Reference Citation Analysis]
9 Voogd L, Ruibal P, Ottenhoff TH, Joosten SA. Antigen presentation by MHC-E: a putative target for vaccination? Trends in Immunology 2022. [DOI: 10.1016/j.it.2022.03.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Klenerman P, Fergusson JR. Cellular Immunology: Transcriptional Basis of B and T Cell Lineages and Memory Cells – T Cell Memory to Viral Infections. Reference Module in Life Sciences 2022. [DOI: 10.1016/b978-0-12-821618-7.00135-8] [Reference Citation Analysis]
11 Bansal A, Gehre MN, Qin K, Sterrett S, Ali A, Dang Y, Abraham S, Costanzo MC, Venegas LA, Tang J, Manjunath N, Brockman MA, Yang OO, Kan-Mitchell J, Goepfert PA. HLA-E-restricted HIV-1-specific CD8+ T cell responses in natural infection. J Clin Invest 2021;131:148979. [PMID: 34228645 DOI: 10.1172/JCI148979] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
12 Barrenäs F, Hansen SG, Law L, Driscoll C, Green RR, Smith E, Chang J, Golez I, Urion T, Peng X, Whitmore L, Newhouse D, Hughes CM, Morrow D, Randall KT, Selseth AN, Ford JC, Gilbride RM, Randall BE, Ainslie E, Oswald K, Shoemaker R, Fast R, Bosche WJ, Axthelm MK, Fukazawa Y, Pavlakis GN, Felber BK, Fourati S, Sekaly RP, Lifson JD, Komorowski J, Kosmider E, Shao D, Song W, Edlefsen PT, Picker LJ, Gale M Jr. Interleukin-15 response signature predicts RhCMV/SIV vaccine efficacy. PLoS Pathog 2021;17:e1009278. [PMID: 34228762 DOI: 10.1371/journal.ppat.1009278] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
13 Royston L, Isnard S, Lin J, Routy JP. Cytomegalovirus as an Uninvited Guest in the Response to Vaccines in People Living with HIV. Viruses 2021;13:1266. [PMID: 34209711 DOI: 10.3390/v13071266] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
14 Walker BD. CMV, MHC-E, and the quest for an unconventional AIDS vaccine. Sci Immunol 2021;6:eabi5830. [PMID: 33990380 DOI: 10.1126/sciimmunol.abi5830] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Yang H, Rei M, Brackenridge S, Brenna E, Sun H, Abdulhaqq S, Liu MKP, Ma W, Kurupati P, Xu X, Cerundolo V, Jenkins E, Davis SJ, Sacha JB, Früh K, Picker LJ, Borrow P, Gillespie GM, McMichael AJ. HLA-E-restricted, Gag-specific CD8+ T cells can suppress HIV-1 infection, offering vaccine opportunities. Sci Immunol 2021;6:eabg1703. [PMID: 33766848 DOI: 10.1126/sciimmunol.abg1703] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
16 Verweij MC, Hansen SG, Iyer R, John N, Malouli D, Morrow D, Scholz I, Womack J, Abdulhaqq S, Gilbride RM, Hughes CM, Ventura AB, Ford JC, Selseth AN, Oswald K, Shoemaker R, Berkemeier B, Bosche WJ, Hull M, Shao J, Sacha JB, Axthelm MK, Edlefsen PT, Lifson JD, Picker LJ, Früh K. Modulation of MHC-E transport by viral decoy ligands is required for RhCMV/SIV vaccine efficacy. Science 2021;372:eabe9233. [PMID: 33766941 DOI: 10.1126/science.abe9233] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]